This inventor holds 1 USPTO granted patent. Top assignee: Soochow University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Aobing Bai and a Flexible Cardiac Biomaterial
Introduction
Aobing Bai is an inventor associated with Soochow University in Suzhou, China. His patent work concerns a flexible, conductive material designed to adhere to organ tissue and support treatment of heart conditions. The available information identifies 1 patent associated with him.
Latest Patents
Bai’s patent, “Flexible Substrate/Liquid Electrolyte Viscous Composite Material and Preparation Method Therefor,” describes a process for making a viscous composite. The method adds a specified proportion of flexible substrate to a liquid electrolyte solution, stirs the mixture at a controlled temperature until the substrate dissolves and disperses evenly, and then allows the resulting viscous liquid to stand under specified conditions.
The patent describes the material as capable of adhering to organ tissue, with mechanical properties intended to match cardiac muscle. It also identifies biocompatibility, conductivity, and in vivo degradability as material characteristics. Proposed uses include treating acute and chronic myocardial infarction and heart failure, limiting ventricular-wall remodeling, thinning, and fibrosis, and improving myocardial function.
Career Highlights
The available information connects Bai’s invention to Soochow University. The patent highlights an approach to cardiac biomaterials that combines tissue adhesion with flexibility and electrical conductivity.
Collaborations
Ning Sun and Wei Jiang are identified as Bai’s coworkers. The supplied information does not specify their individual roles in the patent or the broader research.
Conclusion
Aobing Bai’s patent presents a flexible, conductive, and degradable composite intended to adhere to cardiac tissue and support research into treatments for myocardial injury and heart failure.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile